134 related articles for article (PubMed ID: 872038)
1. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC; Waalkes TP; Snyder JJ; Simon RM
Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
3. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma.
Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA
Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlation between CEA and breast cancer.
Tormey DC; Waalkes TP
Cancer; 1978 Sep; 42(3 Suppl):1507-11. PubMed ID: 709522
[TBL] [Abstract][Full Text] [Related]
6. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
Colomer R; Ruibal A; Salvador L
Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
9. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
Lokich JJ; Zamcheck N; Lowenstein MW
Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
12. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
[TBL] [Abstract][Full Text] [Related]
13. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
15. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
Hayes DF; Zurawski VR; Kufe DW
J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen and breast carcinoma antigen (CA 15.3) in preoperative staging and postoperative monitoring of patients with carcinoma of the breast.
Omar YT; Behbehani AE; al-Naqeeb N; Motawy MM; Folldi MO; Awwad AH; Nasralla MY; Szymendera JJ
Int J Biol Markers; 1988; 3(3):165-71. PubMed ID: 3230336
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
Paulick R; Caffier H
Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
[TBL] [Abstract][Full Text] [Related]
18. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.
Bhatavdekar JM; Balar DB; Shah NG; Trivedi SN; Bhaduri A; Patel DD; Karelia NH; Shukla MK; Ghosh N
Tumour Biol; 1987; 8(5):233-40. PubMed ID: 3448770
[TBL] [Abstract][Full Text] [Related]
19. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
[TBL] [Abstract][Full Text] [Related]
20. Biological markers for breast carcinoma.
Waalkes TP; Enterline JP; Shaper JH; Abeloff MD; Ettinger DS
Cancer; 1984 Feb; 53(3 Suppl):644-51. PubMed ID: 6692267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]